Ignite Creation Date:
2024-05-19 @ 5:34 PM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06411743
Status:
COMPLETED
Last Update Posted:
2024-05-13
First Post:
2024-03-29
Brief Title:
Phase IIIII of Recombinant Human Albumin Injection
Sponsor:
The First Hospital of Jilin University
Organization:
The First Hospital of Jilin University
Organization Data
Organization:
The First Hospital of Jilin University
Class:
OTHER
Study ID:
ART-2021-005
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
The First Hospital of Jilin University
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None